TipRanks
Advertisement
Advertisement

DE:B9A Stock Latest News

BioArctic’s Leqembi Begins First Real-World Use in Sweden After EU Approval
Company AnnouncementsBioArctic’s Leqembi Begins First Real-World Use in Sweden After EU Approval
12d ago
Japan Approves At-Home Leqembi Pen for Early Alzheimer’s Treatment
PremiumCompany Announcements
Japan Approves At-Home Leqembi Pen for Early Alzheimer’s Treatment
19d ago
BioArctic Partner Eisai Wins China Approval for At-Home Leqembi Alzheimer’s Autoinjector
PremiumCompany Announcements
BioArctic Partner Eisai Wins China Approval for At-Home Leqembi Alzheimer’s Autoinjector
1M ago
BioArctic’s Leqembi Wins Key Canadian Reimbursement Backing
PremiumCompany Announcements
BioArctic’s Leqembi Wins Key Canadian Reimbursement Backing
1M ago
BioArctic Updates Share and Vote Structure After Stock Option Exercise
PremiumCompany Announcements
BioArctic Updates Share and Vote Structure After Stock Option Exercise
1M ago
BioArctic Deepens Alzheimer’s Footprint With Leqembi Expansion and New Strategic Alliances
PremiumCompany AnnouncementsBioArctic Deepens Alzheimer’s Footprint With Leqembi Expansion and New Strategic Alliances
1M ago
BioArctic and Eisai Expand At-Home Alzheimer’s Treatment With U.S. Launch of Leqembi Iqlik
Premium
Company Announcements
BioArctic and Eisai Expand At-Home Alzheimer’s Treatment With U.S. Launch of Leqembi Iqlik
1M ago
B9A Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
B9A Upcoming Earnings Report: What to Expect?
1M ago
BioArctic and Mesenkia team up on novel glioblastoma therapy
PremiumCompany Announcements
BioArctic and Mesenkia team up on novel glioblastoma therapy
2M ago
BioArctic schedules August 26 webcast for Q2 2026 report
PremiumCompany Announcements
BioArctic schedules August 26 webcast for Q2 2026 report
2M ago
BioArctic’s Leqembi Royalties Surge on Strong Global Q2 Sales
PremiumCompany Announcements
BioArctic’s Leqembi Royalties Surge on Strong Global Q2 Sales
2M ago
Real-World Study Backs Long-Term Stability on BioArctic–Eisai Alzheimer’s Drug Leqembi
PremiumCompany Announcements
Real-World Study Backs Long-Term Stability on BioArctic–Eisai Alzheimer’s Drug Leqembi
3M ago
BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s
PremiumCompany AnnouncementsBioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s
3M ago
Subcutaneous Leqembi Autoinjector Matches IV Exposure, Promises More Flexible Alzheimer’s Care
Premium
Company Announcements
Subcutaneous Leqembi Autoinjector Matches IV Exposure, Promises More Flexible Alzheimer’s Care
3M ago
BioArctic and Eisai to unveil expansive lecanemab data at AAIC 2026
Premium
Company Announcements
BioArctic and Eisai to unveil expansive lecanemab data at AAIC 2026
3M ago
BioArctic Taps Lilly in Fourth BrainTransporter Partnership
PremiumCompany Announcements
BioArctic Taps Lilly in Fourth BrainTransporter Partnership
3M ago
BioArctic Updates Share and Vote Count After Stock Option Exercise
PremiumCompany Announcements
BioArctic Updates Share and Vote Count After Stock Option Exercise
4M ago
BioArctic AGM Backs Dividend, New Share Mandate and Employee Incentive Plan
PremiumCompany Announcements
BioArctic AGM Backs Dividend, New Share Mandate and Employee Incentive Plan
4M ago
Eisai Sees Strong 2028 Sales Potential for BioArctic’s Alzheimer’s Drug Leqembi
PremiumCompany Announcements
Eisai Sees Strong 2028 Sales Potential for BioArctic’s Alzheimer’s Drug Leqembi
4M ago
BioArctic lifts royalties and milestones as Leqembi expands globally amid mixed regulatory signals
PremiumCompany AnnouncementsBioArctic lifts royalties and milestones as Leqembi expands globally amid mixed regulatory signals
5M ago
Is B9A a Buy, Before Earnings?
Premium
Pre-Earnings
Is B9A a Buy, Before Earnings?
5M ago
BioArctic Set for Strong Royalty Lift as Eisai Hikes Leqembi Sales Outlook
Premium
Company Announcements
BioArctic Set for Strong Royalty Lift as Eisai Hikes Leqembi Sales Outlook
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >